Med-tech firms raising money in public or private financings, including: Telesis Bio, Volitionrx.

New hires and promotions in the med-tech industry, including: Cypher Surgical, CN Bio, Imperative Care, Irhythm, Nevro, Medcura, Zephyr AI.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Amarin, American Regent, Ascentage, Astrazeneca, Beigene, Biophytis, Canbridge, Cocrystal, Daiichi Sankyo, Eddingpharm, Gilead, Hutchmed, Innovent, Inventiva, Novavax, Sino, SK, Takeda.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Adcendo, Affamed, Affyxell, Avacta, Bioray, Biosenic, Celltrion, Cleave, Daewoong, Duality, Impact, J Ints, Jiangsu Nhwa, Lotus, Medsenic, Nascent, Neurogastrx, Nrx, Phebra, Philogen, Rani, Seven and Eight, Sun, Trevena, Yuhan.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko, Alterity, Aum, Beijing Luzhu, Biophytis, Brii, Caliway, Canbridge, Connect, Harbour, Revive, Structure.

Biopharmas in Asia-Pacific raising money in public or private financings: Immutep, Invox, Lynk, Phion, Sino.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Mesoblast, Obi.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anew, Ascendis, Biogen, BMS, Denali, Eureka, Idorsia, Medic, Searchlight, Sol-Gel.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Amolyt, Astrazeneca, Bellerophon, Endo, Enterin, Fogpharma, Harbour, IGM, Immuneering, Newamsterdam, Ractigen, Sirnaomics, Synlogic, Tonix, Vaxess, Vivavision, Walden.

Biopharmas raising money in public or private financings, including: Acepodia, Azitra, Lexicon, Thryv, Zura.